Drugs / IIV-HD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06695117 | Nov 2024 → Apr 2026 | — | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IIV-HD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06695117 ↗ |
| Known as | high-dose inactivated influenza vaccine | “IIV-HD (high-dose inactivated influenza vaccine)” NCT06695117 ↗ |
| Modality | Vaccine | “IIV-HD (high-dose inactivated influenza vaccine)” NCT06695117 ↗ |